Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 32,688 | -85,403 | -276,126 | -228,302 | -340,141 |
| Depreciation Amortization | 2,375 | 4,811 | 5,621 | 6,677 | 11,114 |
| Accounts receivable | 229 | 32,626 | 6,113 | -39,235 | 264 |
| Accounts payable and accrued liabilities | -4,240 | 687 | -3,130 | -9,211 | 9,067 |
| Other Working Capital | -104,735 | -30,959 | 15,341 | -61,468 | 52,584 |
| Other Operating Activity | 22,743 | 9,521 | 59,204 | 61,109 | 46,590 |
| Operating Cash Flow | $-50,940 | $-68,717 | $-192,977 | $-270,430 | $-220,522 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 17,200 | 8,870 | 125,064 | 112,384 | 32,838 |
| PPE Investments | 948 | -246 | -1,198 | -4,193 | -10,580 |
| Other Investing Activity | 0 | 0 | 0 | 94,765 | 0 |
| Investing Cash Flow | $18,148 | $8,624 | $123,866 | $202,956 | $22,258 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 30,605 | N/A |
| Debt Repayment | -250 | -892 | -947 | -518 | -254 |
| Common Stock Issued | 16,349 | 60,181 | 3,064 | 23,812 | 105,459 |
| Other Financing Activity | -1 | -7 | -107 | -815 | -1,261 |
| Financing Cash Flow | $16,098 | $59,282 | $2,010 | $53,084 | $103,944 |
| Beginning Cash Position | 25,176 | 25,987 | 93,088 | 107,478 | 201,798 |
| End Cash Position | 8,482 | 25,176 | 25,987 | 93,088 | 107,478 |
| Net Cash Flow | $-16,694 | $-811 | $-67,101 | $-14,390 | $-94,320 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,940 | -68,717 | -192,977 | -270,430 | -220,522 |
| Capital Expenditure | N/A | -246 | -1,223 | -4,193 | -10,580 |
| Free Cash Flow | -50,940 | -68,963 | -194,200 | -274,623 | -231,102 |